Description of cohorts with 25-hydroxyvitamin D data

1958 British birth cohort (1958BC)
Participants
The 1958BC aimed to include all births during one week in March in England, Scotland and Wales (~17,000). 1 Participants in the study have been followed regularly with information collected on a wide-range of factors related to health, lifestyle, growth and development. At 45 years (August 2002 to March 2004) cohort members were invited to a biomedical survey during which time blood samples were collected. Cognitive tests were carried out when participants were 50 years.
25-hydroxyvitamin D
Serum 25(OH)D concentrations were measured using automated application of the IDS OCTEIA ELISA on the Dade-Behring BEP2000 analyzer (sensitivity of 5.0nmol/L, linearity ≤155nmol/L, and intra-assay CV 5.5-7.2%), with adjustment according to the mean of the Vitamin D External Quality Assessment Scheme.
Outcome
Memory-related cognitive function
 Immediate word recall 2 : Recall as many words as possible from a list of 10 common words read out by interviewer  Delayed word recall 2 : Recall as many words as possible from a list of 10 common words read out by interviewer, following a short delay of approximately 5 minutes
Additional tests for global cognitive function
 Verbal fluency, animal naming : 3 Measures how many words related to a category (in this case, types of animals) a participant can produce  Letter cancellation 4 : Measures speed of processing. Participants were instructed to cross out as many target letters (P and W, 65 in total) as possible in one minute
Genotyping
Genotyping participants in the 1958BC came from two main resources; The Wellcome Trust Case Control Consortium (WTCCC) and the Type 1 Genetics Consortium (T1DGC). Details on how genotyping was conducted have been previously published. [5] [6] [7] [8] [9] Briefly, in the WTCCC, samples were genotyped with the GeneChip 500K Affymetrix chip using the CHIAMO calling algorithm and T1DGC used the Illumina 550k platform. Samples were excluded if the SNP call rate was <97%, heterozygosity >30%, external discordance with genotype or phenotype data, individuals identified as having a recent non-European ancestry, duplicate samples, identity by state (IBS) >86% i.e. likely relatives, minor allele frequency (MAF) <1%, HardyWeinberg p-value <10 -7 .
Covariates
Educational attainment of cohort members was based on the highest qualification obtained by 42 years, or by 33 years if data was missing. Educational attainment was categorised as: none, < O-level or equivalent, O-level or equivalent, A-level or equivalent and > A-level. Depressive symptoms were assessed using the Clinical Interview Schedule-Revised at 45 years. The CIS-R is a standardised semi-structured questionnaire, assessing symptoms in the previous week, a score of ≥2 indicated presence of depressive symptoms 10, 11 .
The Colaus Study (COLAUS)
Participants
The CoLaus study is a prospective study assessing the prevalence and determinants of cardiovascular risk factors and diseases in the adult population in Lausanne, Switzerland 12 .
The baseline study in 2003-2006 included 6,733 representative participants of the population aged 35-75 years. Blood samples were obtained during the baseline study and cognitive tests were conducted on participants aged over 65 years.
25-hydroxyvitamin D
An ultra-high pressure liquid chromatography-tandem mass spectrometry system was developed and validated for the quantification of vitamin D metabolites 25(OH)D3 and 3-epi-25(OH)D3 in human serum samples. 13 The calibrators, 3Plus1 Multilevel Serum Calibrator Set 25-OH-Vitamin D3/D2 (ChromoSystems, Germany), were standardized against the NIST 972 reference material. The inter-day CV% was 4.6% at 40 nmol/L. Analysis for this study was performed on Vitamin D3 levels excluding the epimer 3-epi-25(OH)D3 values.
Outcome
Global cognitive function
 Mini Mental State Examination (MMSE):
14 30 -point questionnaire used to screen for cognitive performance
Genotyping
Samples were genotyped on the Affymetrix GeneChip  Human Mapping 500K using the genotype calling algorithm BRLMM. SNPs with call rates of <70% and individuals with call rates <90% were excluded from further analysis. For imputation, only autosomal SNPs that were present in HapMap release 21 were used. The dataset used for imputation was 390,631 genotyped SNPs with call rate>0.9, Hardy-Weinberg P-value>10-7 and MAF>1%. Imputation was performed using IMPUTE version 0.2.0 and CEU haplotypes from HapMap release 21. Analysis for this study adjusted for four principal components.
Covariates
Educational attainment of the cohort members was categorised as: low (basic or apprenticeship); medium (secondary school); or high (university). Although CoLaus had info on depression, 15 due to a significant drop in sample size, it was not used in this study.
ESTHER
Epidemiologic study assessing chances of prevention, early detection, and treatment of chronic diseases among older adults (Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung ,ESTHER)
Participants
ESTHER is a population-based cohort study conducted in Saarland, Germany. 16 The main aim of ESTHER is to contribute information for the prevention, early detection and treatment of chronic diseases. 17, 18 Participants were recruited during health screening visits to their general practitioners. The baseline sample (2000-2002) included 9,949 participants aged between 50 and 74 years, in which blood samples were collected. Cognitive tests on participants aged ≥65 years were conducted during the follow-up study (2005) (2006) (2007) (2008) . 19 In ESTHER, 25(OH)D concentrations of 780 women with 0 to 29.5nmol/l were recorded as 29.54nmol/l due to the lower detection limit of the Diasorin assay employed to measure the serum sample in 2001. The assay used for men did not have this detection limit. Additionally, in ESTHER, those with >250nmol/l (n=6) were excluded from analyses.
25-hydroxyvitamin D
Outcome The Cognitive Telephone Screening Instrument (COGTEL)
16 was used to assess cognitive function. It consists of the following parameters:
Memory-related cognitive function
 Verbal short-term memory:
20 Recall from a list of 8 word pairs following a short delay  Working memory : 21 In reverse order, recall sequences of single-digit numbers which are presented at a 1 second rate  Verbal long-term memory: 20 Recall from a list of 8 word pairs following a delay during which the other tests were conducted
Additional tests for global cognitive-function  Verbal fluency : 22 Includes two tests, letter fluency i.e. producing as many words as possible beginning with a given letter within 60 seconds and category fluency i.e. producing as many different types of professions as possible within 70 seconds  Inductive reasoning: 21 Involves the continuation of a mathematical sequence
Genotyping
Samples were genotyped using the TaqMan OpenArrayTM SNP Genotyping Platform (Applied Biosystems, Foster City, CA) according to the manufacturer's instructions. The overall call rate was 97.3%. The genotyping concordance was 100%.
Covariates
Educational attainment was categorised as ≤9, 10-11 or ≥12 years in education at mean age of 62.1(SD6.6). Depressive symptoms were assessed using 15-item Geriatric Depression Scale. This is specifically designed for rating depression in the elderly. Cut-off score of 5 was used. 
Helsinki Birth Cohort Study (HBCS)
Participants
The HBCS is a longitudinal study focused on the early origins of health and disease. 24 Information for this study was collected using data from the maternity hospital, clinical, school databases and other registries on people born in 1934-1944 in two hospitals in Helsinki Finland. Blood samples and cognitive testing were administered during the clinical follow-up study (2001) (2002) (2003) ) of 2,003 men and women. Analysis for this study excluded those with a history of stroke (n=107) and those with a discrepancy between reported gender and gender determined by their genotype (n=8).
25-hydroxyvitamin D
Serum 25(OH)D concentrations were measured using the Chemiluminescent Microparticle Immuno Assay (CMIA, Abbott Laboratories, Abbott Park, IL, USA). Analyses were done with an Architect ci8200 -analyzer. The intra-assay CV is 4.3 % + 1.6 % and the detection limit was 5.5 nmol/l.
Outcome
The HBCS uses CERAD (The Consortium to Establish a Registry for Alzheimer's disease) which consists of the following tests: 
Memory-related cognitive function
Additional tests for global cognitive function
 Verbal fluency, animal naming: Measures how many words related to a category (in this case, types of animals) a participant can produce
Genotyping
Genotyping was performed with a modified Illumina 610k chip by the Wellcome Trust Sanger Institute, Cambridge, UK. Genetically related individuals and those with gender discrepancies were excluded. After quality control procedures 1,720 samples remained for the analyses. SNPs were excluded if they met the following conditions: call rate < 0.95, minor allele frequency < 0.01, and HWE test with P < 1x10-5. Genomic coverage was extended to ~2.5M common SNPs by imputation using the HapMap phase II CEU data (NCBI build 36 (UCSC hg18)) as the reference sample and MACH software. SNPs with low imputation quality (rsquared < 0.30), low minor allele frequency (MAF < .01), or that diverged from HWE (1x10-5), were excluded from the analyses. Analyses were adjusted for principal components.
Covariates
Educational attainment was categorised as: folk school/elementary/middle school; learning profession; elementary school or similar; or lower; or higher university degree. Depressive symptoms were assessed using Centre for Epidemiologic Studies Depression Scale with a cut-off of <16.
Northern Finland birth cohort 1966
Participants
The NFBC66 1 is one of the Northern Finland cohorts forming a longitudinal research program aiming to promote health and well-being in the population. The original cohort consisted of 12,231 people born in 1966, with blood samples available for 6,000 participants at 31 years. 25 Cognitive testing was conducted during the 46-year follow-up.
25-hydroxyvitamin D
25(OH)D2 and 25(OH)D3 were measured in four batches using high-performance liquid chromatographytandem mass spectrometry. Further details have been previously published. 26 Analyses for this study were adjusted for vitamin D batch.
Outcome
 Paired Associates Learning (PAL): assess visual memory and new learning
Genotyping
Genotyping was conducted using Infinium 370cnvDuo, keeping MAF > 0.01, call rate > 0.95 (0.99 for MAF < 0.05), HWE p-value > 1e-6. Subjects with overall call rate < 0.95 and gender mismatch were excluded.
Covariates
Educational attainment was categorised into: non occupational education or vocational training course; vocational school or post-secondary education; polytechnic education or university degree. Presence of depression (yes, no) was assessed from responses to following question: "Have you ever had any of the following symptoms, sicknesses or injuries verified or treated by a doctor: depression?"
The Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Participants
The PIVUS 2 study includes men and women aged 70 years in Uppsala, Sweden. The primary aim of this study was to evaluate the usefulness of different measurements of endothelial function and other techniques to evaluate vascular function. The baseline study (2001) (2002) (2003) (2004) consisted of 1,016 participants in which blood samples were obtained. Cognitive tests were conducted in the follow-up sweep (~75ys). 27 Consists of (1) Benton temporal orientation i.e. measurement of orientation in time (2) Clock drawing i.e. subject draws the face of a clock and places the hands on a fixed time (3) 
25-hydroxyvitamin D
Genotyping
SNPs were genotyped as part of a larger study at the SNP technology platform at Uppsala University (http://www.genotyping.se/) on an Illumina BeadStation 500GX using Infinium iSelect and Golden Gate assays from Illumina Inc. 28 Genotyping calls were performed with Illumina BeadStudio or GenCall software. Samples with low call rate (<90%), excess heterozygosity or cryptic relatedness were excluded from analyses. SNPs with a call rate less than 90%, or that failed HWE (exact p-value<1x10-6) were excluded from the study.
Covariates
Educational attainment was categorised as primary school (<9 years), secondary school (9-12 years), university level (>12 years) at mean age of 70.2(SD0.2). There was no information on depressive symptoms.
The Tromsø Study (Tromsø)
Participants
Tromsø is a longitudinal population-based multi-purpose study focusing on lifestyle-related diseases in Norway. It began in 1974 with 6,595 male participants. Blood collection was conducted in Tromsø 4 (1994 Tromsø 4 ( -1995 29 and cognitive tests were conducted in Tromsø 5 (2001, n=8,130) . 29 31 Participant is asked to tap as many times as possible in 10 seconds with their index finger on a computer  Digit symbol coding test: 21 Consists of rows containing blank squares, each paired with a randomly assigned number from one to nine, and a printed key about that pair, each number with a different nonsense symbol. Participants consecutively fill-in as many as possible of the blank spaces with the corresponding symbol as quickly as possible for 90 seconds
25-hydroxyvitamin D
Genotyping
Genotyping was conducted by KBioscience (http://www.kbioscience.co.uk) using KASP (KBioScience AlleleSpecific Polymorphism) SNP genotyping system. Two separate manual quality control checks were performed, and the data was also checked by specific software to determine that there were no incorrect call assignments, no samples too close or too far from the origin, no NTCs amplified, or any incorrect calls. The call rate for all the 4 SNPs was >98 % and the Hardy-Weinberg equilibrium p value was p> 0.01.
Covariates
Educational attainment was a continuous variable measuring years of education by mean age of 64.5(SD9.9). Depressive symptoms were assessed using Hopkins symptom checklist-10 which is a self-reported symptom inventory consisting of symptoms commonly observed in the population 32 with responses as yes or no.
Uppsala Longitudinal Study of Adult Men (ULSAM)
Participants ULSAM is a longitudinal study based on all men born between 1920 and 1924 in Uppsala, Sweden. The study began in 1970 when the men were 50 years (n=2,322). 33 The main aim of the study was to identify cardiovascular risk factors. Blood collection and cognitive testing was conducted when participants were age 70 years (1991-1995). 
25-hydroxyvitamin D
Outcome
Global cognitive function
 MMSE: 14 30-point questionnaire used to screen for cognitive impairment  TMT A: 34 Participant is asked to draw lines with a pencil between the numbers in the right order as fast as possible. The score is equal to the time in seconds. TMT A consists of digits 1-25  TMT B: 34 Participants is asked to draw lines with a pencil between the numbers in the right order as fast as possible. The score is equal to the time in seconds. TMT B consists of digits and letters 1-A-2-B etc.
Genotyping
As for PIVUS, SNPs were genotyped at the SNP technology platform at Uppsala University (http://www.genotyping.se/) on an Illumina BeadStation 500GX using Infinium iSelect and Golden Gate assays from Illumina Inc. Genotyping calls were performed with Illumina BeadStudio or GenCall software. Samples with low call rate (<90 %), excess heterozygosity or cryptic relatedness were excluded from analyses. SNPs with a call rate less than 90%, or that failed (exact P-value<1x10-6) were excluded from the study.
Covariates
Educational attainment was categorised as 7, 8-10 or ≥12 years in education. Depressive symptoms were assessed using International classification of disease 35 with responses as yes or no.
Young Finns Study (YFS)
Participants
The Cardiovascular Risk in Young Finns Study (YFS) is an ongoing longitudinal population-based study focusing on cardiovascular risk factors from childhood to adulthood. The study was originally designed as a national collaborative effort between all university hospitals and several other institutions in Finland. The first cross-sectional study of the YFS was performed in 1980, and it included 3,596 randomly selected children and adolescents (both boys and girls) aged 3, 6, 9, 12, 15 and 18 years. Until the year 2011, the cohort has been regularly followed-up in 3-9 year intervals. More detailed information on the YFS study population and protocol is reported elsewhere. 36 Blood samples were collected in the 2007 wave and cognitive tests were conducted in 2011.
25-hydroxyvitamin D
Blood samples were stored at 70°C and analysed in 2008. Serum 25(OH)D was analysed by radioimmunoassay (RIA) (DiaSorin, Inc.). The limit of detection was 3.8 nmol/L. The interassay coefficient of variation (CV) was 8.5% (n=128) at the level of 35.7 nmol/L, and 8.8% (n =113) at the level of 135.3 nmol/L. 37 
Outcome
Memory-related cognitive test
 Paired associates learning (PAL) test: assessed visual and episodic memory as well as visuospatial associative learning containing aspects of both delayed response procedure and conditional learning. During the PAL test, either 1, 2, 3, 6, or 8 patterns were displayed sequentially in boxes placed on the screen. After that, the patterns were presented in the center of the screen, and the participants were supposed to point the box in which the particular pattern was previously seen. The test moves on to the next stage if all the patterns were placed to right boxes. In case of incorrect response, all the patterns were re-displayed in their original locations and another recall phase was followed. The test terminated if the patterns were still incorrectly placed after 10 presentation and recall phases
Additional tests for global cognitive function
 Spatial working memory (SWM) test: measures ability to retain spatial information and to manipulate items stored in the working memory, problem solving as well as the ability to conduct a self-organized search strategy. During this test the participants were presented with randomly distributed coloured boxes ranging in number from 4 to 8. After that, the participants searched for tokens hidden in the boxes. When a token was found it was to be moved to fill an empty panel on the right-hand side of the screen. Once the token had been moved from the box, the participant had to recall that the computer would never hide a new token in a box that previously contained one; therefore the participants were not supposed to revisit the same boxes again  Reaction time (RTI) test: assesses speed of response and movement on tasks where the stimulus was either predictable (simple location task) or unpredictable (five-choice location task). In the first part of this test, a large circle was presented in the center of the screen. The participant was supposed to press a button on a press pad until a small yellow spot appears in the large circle. When the yellow spot appeared the participant was supposed to touch the spot as soon as possible with the same hand that was pressing the button on the press pad. In the second part of the test, the same task was performed, except that in this part five large circles were presented on the screen, and the small yellow spot might appear in any of the five circles. Again the participant was supposed to touch, as soon as possible, the yellow spot with the hand pressing the button on the press pad  Rapid visual information (RVP) test: assess visual processing, recognition and sustained attention. In this test the participant was presented with a number sequence (e.g. 3, 5, 7) next to a large box where numbers appeared in a random order. Whenever the particular sequence was presented, the participant was supposed to press a button on a press pad. At the beginning, the participant was given visual cues (i.e. colored or underlined numbers) to help to recognize the particular sequence. When the test proceeded, the cues were removed.
Genotyping
Genomic DNA was extracted from peripheral blood leukocytes using a commercially available kit and the Qiagen BioRobot M48 Workstation according to the manufacturer's instructions (Qiagen, Hilden, Germany). Genotyping was performed on 2,556 samples using a custom-built Illumina Human 670k BeadChip at the Welcome Trust Sanger Institute. Genotypes were called using the Illuminus clustering algorithm. Fifty-six samples failed to meet the Sanger genotyping pipeline QC criteria (i.e. duplicated samples, heterozygosity, low call rate, or Sequenom fingerprint discrepancy). Out of the remaining 2,500 samples, one failed the gender check, and three were removed due to low genotyping call rate (< 0.95) and 54 for possible relatedness (pi-hat > 0.2). Based on the Hardy-Weinberg equilibrium (HWE) test, 11,766 SNPs were excluded (p < 1e-6), and 7,746 SNPs failed the missingness test (call rate < 0.95) and another 34,596 SNPs failed the frequency test (MAF < 0.01). After quality control, 2,442 samples and 546,677 genotyped SNPs were available for further analysis. Genotype imputation was performed using IMPUTE2 and 1000 Genomes Phase I Integrated Release Version 3 (March 2012) haplotypes as a reference. 38 Analyses adjusted for principle components.
Covariates
Educational attainment was categorised as: low level (vocational school, vocational college); medium level (university or applied sciences, university studies (no final degree), Bachelors degree); or high level(Masters, Licentiate degree, Doctoral degree), Depression data were taken from self-reported data on depression diagnoses in 2007.
Description of cohorts without 25-hydroxyvitamin D data
Austria Stroke Prevention Study (ASPS)
Participants
The ASPS is a prospective study on the effects of vascular risk factors on brain structure and function in cognitively normal inhabitants of Graz, Austria. 39, 40 2,007 participants aged 45 to 86 years were recruited from the official community register and all participants were free of stroke and dementia. Individuals were excluded from the study if they had a history of neuropsychiatric disease. Between 1991 and 1994, 509 participants randomly selected from the entire cohort underwent cognitive testing. To enlarge the cohort with imaging and neuropsychological assessments, an additional 567 individuals were randomly selected in a second study between 1999 and 2003. Participants of the first and second panels were pooled, which resulted in a total of 1,076 individuals with blood and cognitive tests. 
Genotyping
Genotyping was done at the Human Genotyping Facility, Genetic Laboratory Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands, using the Illumina Human610-Quad BeadChip. Participant-specific quality controls included filters for call rate (<98%), and high autosomal heterozygosity (FDR <1%). Quality filters used a call rate >98%, a minor allele frequency >0.01 and a Hardy-Weinberg p>1x10-6. In total, 550635 markers and 856 people passed all criteria. ASPS used the Markov Chain Haplotyping (MaCH) package(http://www.sph.umich.edu/csg/abecasis/MACH, version 1.0.15 for imputation to plus strand of NCBI build 36, HapMap release #22.
Covariates
Educational attainment was categorised as 9, 10, 13 or 18 years in education. Depressive symptoms were assessed using Eigenschaftswörterliste (range 0-15). This is a validated multidimensional tool consisting of a list of given adjectives describing the emotional status of a test person at the time of the interview. 
English Longitudinal Study of Ageing (ELSA)
Participants
ELSA is an English based study consisting of men and women aged 50 years and over. It is a follow-up study of respondents to the Government's Health Survey for England (HSE) 3 , an annual cross-sectional survey designed to be representative of the community-based population in England. The main objective of ELSA is to collect longitudinal multidisciplinary data relating to health, disability, biological markers, well-being, social participation and economics. ELSA began in 2002 and has been followed up every two years. The sample consists of individuals seen in HSE in 1998, 1999 or 2001. 11,391 participants were interviewed for wave 1 (2002) in which cognitive testing was conducted. 42 4 Measures speed of processing. Participants were instructed to cross out as many target letters (P and W, 65 in total) as possible in one minute.
Genotyping
DNA was extracted from blood samples using magnetic bead technology (Medical Solutions, Nottingham). Genotyping was performed using the KASPar methodology. The call rates and the concordance rates of the four SNPs were >98%, HWE values were p>0.08.
Covariates
There was no information on educational attainment. Depressive symptoms were assessed using the 8-item Centre for Epidemiologic Studies Depression Scale. This is a short self-report scale design to measure depressive symptomatology based on the past week in the general population with higher summary scores indicating greater symptoms. 43 A cut-off score of 3 was used and has been shown to be clinically significant for 8-item questionnaire and cut-off of 16 for longer version. 
Health and Retirement Study (HRS)
Participants
The HRS is an ongoing nationally representative study with biannual assessments as previously described. 45 Data for this study comes from older Americans with European ancestry who participated in the 2006 wave of the US HRS. The interviewer asked the respondent to subtract 7 from 100, and continue subtracting 7 from each subsequent number for a total of five trials. It was up to the respondent to remember the value from the prior subtraction, such that the interviewer did not repeat the difference said by the respondent after each trial.  Backwards count: respondents were asked to count backwards for 10 continuous numbers beginning with the number 20.
Genotyping
DNA samples from buccal swabs were genotyped in batches at the National Institutes of Health Center for Inherited Disease Research using the Ilumina Human Omni-2.5 Quad beadchip. 7 Analyses were adjusted for principle components
Covariates
Educational attainment was categorised into number of tertiles based on number of years in school. Depression was based on CESD (0-8) total score with a cut-off of 4 or more indicative of depression if <2 of the 8 items missing as previously described . 46 
Swedish Twin Registry (STR)
Participants
The participants of STR were taken from longitudinal twin studies of aging. All these studies have previously been described in detail and are sub-samples of the population based Swedish Twin Registry. [47] [48] [49] The study consists of The Swedish Adoption/Twin Study of Aging (SATSA) with up to ten longitudinal occasions and the GENDER study with three interview occasions. All participants are of European ancestry and born in Sweden. For these sub-samples, individuals participated in at least one in-person session and in which a blood sample was drawn. Analyses were adjusted for study name i.e. SATSA or GENDER. Blood samples and cognitive tests were taken at wave 1 in GENDER and at the first availability from wave 3 to wave 9 in SATSA. 
Genotyping
Samples were genotyped using Metabochip, which were used in Study II. 50 Genotyping was performed at Uppsala University SNP Technology Platform using the Illumina iSelect Metabochip genotyping array. Call rate > 90%.
Covariates
Educational attainment was categorised as: elementary or middle school; high school or equilivant; college or higher. Presence of depression was examined through review or medical record, CES-D, depression diagnosis in the National Patient Register
TwinGene
Participants
The TwinGene project, conducted between 2004 and 2008, is a population-based Swedish study of twins born between 1911 and 1958. 51 The study participants have previously participated in a telephone interview called Screening Across the Lifespan Twin Study, conducted between 1998 and 2002. To be included in TwinGene, both twins within a pair had to be alive. The zygosity of the twins was based on self-reported childhood resemblance, or by using DNA markers (for 18% of the total sample). In total, 12,591 individuals participated by donating blood to the study, and by answering questionnaires about life style and health. The study was approved by the local ethics committee at Karolinska Institutet and all participants gave informed consent. 8 Constructed from immediate word recall, delayed word recall, similarity test (see footnote for full details).
Genotyping
TwinGene participants were genotyped with Illumina Human OmniExpress (≈700,000 SNPs); genotype rate per SNP greater than 95%; genotype rate per individual greater than 97%.
Covariates
Educational attainment was categorised as: elementary or middle school; high school or equivalent; college or higher. Depression was assessed through CES-D, antidepressant use and doctor screening items.
UK Biobank
Participants UK Biobank is a large prospective study with over 500,000 participants from across the United Kingdom aged 40-69 years at recruitment in 2006-2010 9 . The study has data from questionnaires, physical measures, sample assays, accelerometry, multimodal imaging, genome-wide genotyping and longitudinal follow-up for a large number of health-related outcomes. In the current study, we use the interim UK Biobank genetic data that comprise more than 150,000 samples. We have restricted the analyses to individuals genetically defined as Caucasian and to persons that are unrelated.
Outcome
Memory-related cognitive tests  Pairs matching tests:
10 This category contains data on 'pairs' matching tests. Participants are asked to memorise the position of as many matching pairs of cards as possible. The cards are then turned face down on the screen and the participant is asked to touch as many pairs as possible in the fewest tries. Multiple rounds were conducted. The first round used 3 pairs of cards and the second 6 pairs of cards. In the pilot phase an additional (i.e. third) round was conducted using 6 pairs of cards. however this was dropped from the main study as the extra set of results were very similar to the second and not felt to add significant new information. This category includes data on the number of columns (i.e. 3 or 4), number of rows (i.e. 2 or 3) and the number of correct and incorrect matches.
Additional tests for global cognitive function  Reaction time:
11 This category contains data on a test to assess reaction time and is based on 12 rounds of the card-game 'Snap'. The participant is shown two cards at a time; if both cards are the same, they press a button-box that is on the table in front of them as quickly as possible. For each of the 12 rounds, the following data were collected: the pictures shown on the cards (Index of card A, Index of card B), the number of times the participant clicked the 'snap' button, and the time it took to first click the 'snap' button.
Additional cognitive tests for sensitivity analyses  Fluid intelligence (i.e. Reasoning) 12 : This tests the capacity to solve problems requiring reasoning, logic and acquired knowledge. The participant is given two minutes to complete as many questions as possible  Prospective memory: Information on how the prospective memory test was conducted can be found:
http://biobank.ctsu.ox.ac.uk/crystal/label.cgi?id=100031
Genotyping
Approximately 450,000 of the participants have been/are being genotyped using the UK Biobank Axiom array from Affymetrix. There are approximately 800,000 markers on this array. The other approximately 50,000 samples were genotyped on the closely related UK BiLEVE array. These are two very similar arrays with more than 95% common marker content. The analysis sample was restricted to unrelated individuals, based on a threshold of 0.05 estimated from genetic kinships, and to individuals of Caucasian genetic ancestry using principal components analyses (PCA). Analyses were adjusted for principle components.
Covariates
Educational attainment categorised as: none, NVQ/CSE/O-levles/A-levels or degree/professional. Presence of depression was obtained from the question "In the last 2 weeks, how often have you felt down, depressed or hopeless? With the responses: several, more than half the days, nearly every day or, not at all.
The UK Household Longitudinal Study (Understanding Society) UKHLS
Participants
The 
Additional tests for global cognitive function
 Subtract 7 test: Participant subtracts 7 from 100, and continue subtracting 7 from each subsequent number for a total of five trials
Genotyping
Genotyping was conducted at the Wellcome Trust Sanger Institute, Hinxton using Illumina Human Core Exome Bead chip. The overall call rate was <98%.
Covariates
Educational attainment was categorised as: Low: no qualification or GCSE and equivalent, Medium: A level and equivalents, High: Undergraduate agree and higher. Depression was categorised as yes or no based on clinical presentation.
Whitehall II (WII)
Participants WII was established in 1985 with the aim of investigating the importance of socioeconomic difference in physical, mental illness and mortality in London-based offices of 20 Civil Service departments. 53 DNA preparation and cognitive testing was conducted using information from phase 7 (2002-2004, n=6,967) .
Outcome
Memory-related cognitive tests:
 Memory test score: 54 Recall in writing as many of the 20 two syllable words in any order within two minutes
Additional tests for global cognitive function
 Alice-Heim 4 : 55 Composed of a series of 65 verbal and mathematical reasoning items of increasing difficulty. It tests inductive reasoning, measuring the ability to identify patterns and infer principles and rules. Participants had 10 minutes to do this section  Mill Hill Score: 56 Vocabulary was assessed using the multiple choice format consisting of a list of 33 stimulus words ordered by increasing difficulty and six response choices  Verbal fluency (phonemic): 57 Recall in writing as many words beginning with 's' as they could in one minute  Verbal fluency (semantic): 57 Recall in writing as many animal names as they could in one minute
Genotyping
DNA was extracted from blood samples using magnetic bead technology (Medical Solutions, Nottingham). Genotyping was performed using the Illumina 50K IBC CVD chip or KASPar methodology. The call rates and the concordance rates of the four SNPs were >98%. The HWE p values were p>0.07.
Covariates
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Supplementary
1958BC rs12785878 DHCR7 G/T 0·22 0·49 Genotyped rs12794714 CYP2R1 A/G 0·43 0·59 Genotyped COLAUS rs2276360 DHCR7 G/C 0·28 0·62 Genotyped rs12794714 CYP2R1 A/G 0·47 0·73 Imputed ESTHER rs11603330 DHCR7 A/C 0·26 0·71 Genotyped rs12794714 CYP2R1 A/G 0·46 0·95 Genotyped HBCS rs7944926 DHCR7 A/G 0·38 0·43 Genotyped rs12794714 CYP2R1 G/A 0·39 0·14 Genotyped NFBC66 rs7944926 DHCR7 A/G 0·39 0·03* Genotyped rs11023350 CYP2R1 G/T 0·41 0·65 Genotyped PIVUS rs12785878 DHCR7 C/A 0·35 0·06 Genotyped rs12794714 CYP2R1 G/A 0·40 0·78 Genotyped TROMSØ rs12785878 DHCR7 G/T 0·39 0·46 Genotyped rs12794714 CYP2R1 A/G 0·41 0·34 Genotyped ULSAM rs12785878 DHCR7 C/A 0·33 0·64 Genotyped rs7938266 CYP2R1 G/A 0·39 0·62 Genotyped YFS rs12785878 DHCR7 G/T 0·40 0·17 Genotyped rs12794714 CYP2R1 A/G 0·38 0·27 Imputed
Studies without 25(OH)D:
ASPS rs12785878 DHCR7 G/T 0·29 0·19 Imputed rs12794714 CYP2R1 A/G 0·44 0·72 Imputed ELSA rs12785878 DHCR7 G/T 0·22 0·08 Genotyped rs12794714 CYP2R1 A/G 0·43 0·82 Genotyped HRS rs12785878 DHCR7 G/T 0·27 <0·001* Imputed rs12794714 CYP2R1 A/G 0·44 0·62 Genotyped STR rs736894 DHCR7 T/C 0·30 0·17 Imputed rs12794714 CYP2R1 A/G 0·39 0·79 Imputed TwinGene rs12785878 DHCR7 G/T 0·33 0·78 Imputed rs12794714 CYP2R1 A/G 0·40 0·09 Genotyped UK Biobank rs12785878 DHCR7 G/T 0·21 0·30 Genotyped rs12794714 CYP2R1 A/G 0·42 0·97 Genotyped UKHLS rs12785878 DHCR7 G/T 0·22 0·46 Genotyped rs12794714 CYP2R1 A/G 0·42 0·43 Genotyped WII rs12785878 DHCR7 G/T 0·23 0·73 Genotyped rs12794714 CYP2R1 A/G 0·43 0·49 Genotyped G:
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